Brightworth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,487
| Closed | -$716K | – | 121 |
|
|
2021
Q4 | $716K | Buy |
11,487
+2,292
| +25% | +$143K | 0.07% | 75 |
|
|
2021
Q3 | $544K | Buy |
9,195
+473
| +5% | +$28K | 0.05% | 75 |
|
|
2021
Q2 | $583K | Buy |
8,722
+132
| +2% | +$8.82K | 0.05% | 66 |
|
|
2021
Q1 | $542K | Buy |
8,590
+1,078
| +14% | +$68K | 0.05% | 66 |
|
|
2020
Q4 | $466K | Buy |
7,512
+1,428
| +23% | +$88.6K | 0.05% | 67 |
|
|
2020
Q3 | $367K | Buy |
6,084
+1,404
| +30% | +$84.7K | 0.04% | 70 |
|
|
2020
Q2 | $275K | Buy |
+4,680
| New | +$275K | 0.04% | 70 |
|
|
2018
Q2 | – | Sell |
-3,426
| Closed | -$217K | – | 97 |
|
|
2018
Q1 | $217K | Sell |
3,426
-159
| -4% | -$10.1K | 0.05% | 113 |
|
|
2017
Q4 | $220K | Sell |
3,585
-67
| -2% | -$4.11K | 0.05% | 111 |
|
|
2017
Q3 | $233K | Buy |
+3,652
| New | +$233K | 0.06% | 112 |
|